Hodkin lymphoma cancer

Also known as Hodgkin's disease, this form of cancer originates in the lymph nodes (glands) in the lymphatic system, which produce the cells responsible for immunity and blood vessels that lead from the body. It can occur at any age, but the incidence of lymphoma is higher in young adults between 25 and 30 years. The disease arises when a lymphocyte (a type of white blood cell) cell becomes malignant, can grow uncontrollably and spread. The cell begins producing malignant lymph nodes identical copies (also called clones). With the passage of time, there is risk that these malignant cells disseminate to neighboring tissues and, if left untreated, reaching other parts of the body. Over the past 50 years, the number of cases remained stable, while the mortality was reduced by more than 60% since the early 70s due to advances in treatment. Most patients with Hodgkin's lymphoma can be cured with appropriate treatment.
Treatment
Hodgkin's disease is curable when treated properly. The classical treatment is multidrug therapy (chemotherapy with multiple drugs), with or without associated radiotherapy. For patients who suffer relapse (return) of the disease, the alternatives will depend on the initial form of treatment. The options typically employed and with relatively precise indications are multidrug therapy and bone marrow transplantation.

Patients should be monitored continuously after treatment with periodic consultations, which may go progressively increasing intervals.
Prevention
People with compromised immune systems as a result of inherited genetic diseases, HIV infection and immunosuppressive drugs, have slightly higher risk of developing Hodgkin's disease. Members of families in which one or more persons had a diagnosis of the disease also have an increased risk of developing it.